Institute of Sports Sciences and Medicine
Tallahassee, Florida, 32306, United States
Location contact
Andrew P Koutnik, PhD
SUB_INVESTIGATOR
Connor R McKay
SUB_INVESTIGATOR
Michael J Ormsbee, PhD
CONTACT
Michael J Ormsbee, PhD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT07771790
The goal of this study is to determine whether consuming a commercially available exogenous ketone supplement (KetoneIQ®) affects cognition, specifically marksmanship, under physical stress (i.e., exhaustive exercise).
The main questions we seek to answer are:
* Does the supplement save cognitive performance under stress compared to a placebo? * Does the supplement improve marksmanship under stress compared to a placebo?
Trial opening soon.
Get Notified18 year and older
All sexes
Interventional
Not applicable
Tallahassee, Florida, 32306, United States
Andrew P Koutnik, PhD
SUB_INVESTIGATOR
Connor R McKay
SUB_INVESTIGATOR
Michael J Ormsbee, PhD
CONTACT
Michael J Ormsbee, PhD
PRINCIPAL_INVESTIGATOR
In this study, 20 active SWAT team members will be randomized into two groups: Exogenous Ketone Supplement (EKS) and Placebo (PLA).
Participants will complete the trial in a crossover manner (meaning each participant will complete both EKS and PLA conditions)
Our primary outcome of interest is changes in cognitive performance following an exhaustive exercise bout. Secondary outcomes include: changes in marksmanship accuracy and speed, and changes in select biomarkers (catecholamines, cortisol, and BDNF).
Although ketone supplements are marketed for energy and cognitive performance, little is known about how they affect biological markers during stressful environments. Findings from this study may help inform safe, evidence-based use of such supplements among tactical athletes.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Acute dosage at 0.6g/kg of bodyweight, split into 2 boluses of 0.4 and 0.2g/kg seperated by 45 mins
Taste, texture, and color matched very low calorie placebo
Time frame: Baseline (minute 0) to Post Suppelementation (minute 45) to Post Exercise (minute 60)
Changes in Score for the Trail Making Test, Psychomotor Vigilance Test, and Flanker Test.
Time frame: Baseline (minute 0) to post supplementation (minute 45) to post exercise (minute 60)
To assess changes in BDNF from baseline to post supplementation to post exercise
Time frame: From baseline (minute 0) to post supplemenation (minute 45) to post exercise (minute 60)
To assess changes in the circulating concentration of epinephrine, norepinephrine, and dopamine
Time frame: From baseline (minute 0) to post supplemetation (minute 45) to post exercise (minute 60)
To assess changes in circulating cortisol between groups
Time frame: Post Exercise (minute 60)
To assess whether potentially improved cognitive performance translates to tactical-specific tasks. Rifle disassembly, reassembly, and functions check. This will be quantified by number of errors and time to completion
Time frame: Post Exercise (minute 60)
To determine whether potentially improved cognitive performance translates to live-round marksmanship. Using HIT Factor scoring (an aggregate of accuracy and time to completion, where a higher number is better), we will assess both accuracy and speed to completion for a shuttle fire drill
Contact information is provided by the study sponsor or research team.
Florida State University
Other
Acronym: TACTIK
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07756658
Cognition, Creatine
Tampa, Florida, United States
View Trial DetailsNCT07752329
Cognition, Fatigue
Newcastle, Newcastle Upon Tyne, United Kingdom
View Trial DetailsNCT07727369
Aging, Cognition
Grenoble, Isère, France
View Trial DetailsNCT07710339
Aging, Behavior
Winstom Salem, North Carolina, United States
View Trial Details